MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Cash Flow Overview

Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Common stock issuance, net
    • Depreciation and amortization
    • Impairment charges
    • Others
Negative Cash Flow Breakdown
    • Repayments of debt-A2025Credit A...
    • Acquisitions of real estate
    • Repurchase of preferred stock
    • Others
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-5,386
-4,281
-22,804
-34,881
Depreciation and amortization
17,811
17,738
17,987
60,274
Amortization of deferred financing costs
-
-
-
3,035
Amortization of deferred financing costs and mortgage discounts (premiums)
1,058
1,044
4,753
-
Accretion of terminated swap
-1,492
-1,476
-344
0
Amortization of mortgage premiums and discounts, net
-
-
-
65
(accretion) amortization of market lease and other intangibles, net
-146
-147
-131
2,022
Bad debt expense
-
-
-
659
Equity-based compensation amortization expense
1,615
612
1,863
1,903
Loss (gain) on non-designated derivative instruments
-
-
-26
-46
(gain) loss on sale of real estate investments
-
-
-467
28,267
Gain on sale of real estate investments
0
0
-
-
Cash received from non-designated derivative instruments
233
375
683
2,609
Gain on non-designated derivative instruments
229
-87
-
-
Impairment charges
3,780
0
11,162
33,752
Gain on extinguishment of debt
0
-
0
257
Deferred tax valuation allowance
43
79
-496
-1,215
Straight-line rent receivable, net
168
268
-3,767
2,412
Prepaid expenses and other assets, net
-360
-597
-10,847
7,155
Termination fees payable to related parties
-
-
-
0
Accounts receivable, net
-2,032
-59
7,790
-4,391
Accounts payable, accrued expenses and other liabilities
3,098
-2,188
-5,382
-35,838
Deferred leasing costs
1,029
738
899
7,182
Deferred rent
113
-2,322
-983
3,013
Net cash provided by (used in) operating activities
21,607
9,013
9,959
-3,008
Acquisitions of real estate
98,031
-
0
250
Capital expenditures
5,344
5,265
11,773
16,953
Investments in non-designated interest rate caps, net
0
154
1,379
0
Proceeds from sales of real estate, net
0
0
9,821
90,340
Net cash (used in) provided by investing activities
-103,375
-5,419
-3,331
73,137
Borrowings/proceeds from credit facility-Credit Agreement
-
-
336,000
-
Borrowings/proceeds from credit facility-Fannie Mae Secured Debt
-
-
0
-
Repayments of fannie mae secured debt
-
1,442
1,442
26,034
Repayments of debt-A2025Credit Agreement
186,000
-
-
-
Proceeds from fannie mae and other secured debt
-
-
-
0
Proceeds from mortgage notes payable
-
-
0
-
Repayments of debt-Fannie Mae Secured Debt
2,885
-
-
-
Repayments of mortgage notes payable
222
221
330,468
645
Proceeds from interest rate swap terminations
-
0
8,259
-
Payments of deferred financing costs
187
-
6,006
205
Proceeds from promissory note
-
-
0
0
Taxes paid for net settlement of equity-based awards
0
444
612
-
Payment of offering costs
3,950
-
1,217
-
Common stock issuance, net
499,422
-
-
-
Repurchase of preferred stock
25,610
-
920
4,503
Distributions paid on preferred stock-Series ACumulative Redeemable Perpetual Preferred Stock
1,772
1,773
1,771
5,410
Contributions from non-controlling interest holders
-
-
0
-
Distributions paid on preferred stock-Series BCumulative Redeemable Perpetual Preferred Stock
1,522
1,521
1,512
4,752
Distributions to non-controlling interest holders
46
46
45
139
Purchase of non-controlling interest
1,125
-
978
-
Net cash provided by (used in) financing activities
277,545
-5,447
-712
-41,688
Net change in cash, cash equivalents and restricted cash
195,777
-1,853
5,916
28,441
Cash, cash equivalents and restricted cash, beginning of period
102,536
102,536
-
74,095
Cash, cash equivalents and restricted cash, end of period
302,376
106,599
-
102,536
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Common stock issuance,net$499,422K Depreciation andamortization$17,811K Impairment charges$3,780K Accounts payable,accrued expenses and...$3,098K Accounts receivable, net-$2,032K Equity-based compensationamortization expense$1,615K Amortization of deferredfinancing costs and...$1,058K Prepaid expenses andother assets, net-$360K Cash received fromnon-designated derivative...$233K Deferred rent$113K Net cash provided by(used in) financing...$277,545K Net cash provided by(used in) operating...$21,607K Canceled cashflow$223,319K Canceled cashflow$8,493K Net change in cash,cash equivalents and...$195,777K Canceled cashflow$103,375K Repayments ofdebt-A2025Credit Agreement$186,000K Repurchase of preferredstock$25,610K Payment of offeringcosts$3,950K Repayments of debt-FannieMae Secured Debt$2,885K Distributions paid onpreferred stock-Series...$1,772K Distributions paid onpreferred stock-Series...$1,522K Purchase ofnon-controlling interest$1,125K Repayments of mortgagenotes payable$222K Payments of deferredfinancing costs$187K Distributions tonon-controlling interest...$46K Net loss-$5,386K Accretion of terminatedswap-$1,492K Deferred leasing costs$1,029K Gain onnon-designated derivative...$229K Straight-line rentreceivable, net$168K (accretion) amortization ofmarket lease and other...-$146K Deferred tax valuationallowance$43K Net cash (used in)provided by investing...-$103,375K Acquisitions of real estate$98,031K Capital expenditures$5,344K

National Healthcare Properties, Inc. (NHPAP)

National Healthcare Properties, Inc. (NHPAP)